SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found...

|About: SciClone Pharmaceuticals, Inc. (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN) -14.1% premarket after announcing that a special committee found evidence of sales and marketing activities that might violate the Foreign Corrupt Practices Act, leading its president of international sales to resign. The drugmaker yesterday reported a decline in Q1 profit.